User profiles for C. Iliescu

Ciprian Iliescu

- Verified email at upb.ro - Cited by 5644

Catrinel Iliescu

- Verified email at umfcd.ro - Cited by 472

Vascular toxicities of cancer therapies: the old and the new–an evolving avenue

J Herrmann, EH Yang, CA Iliescu, M Cilingiroglu… - Circulation, 2016 - Am Heart Assoc
… Other receptor tyrosine kinases (c-kit, fibroblast growth factor-2, and epidermal growth factor
… Reprinted from Iliescu et al 60 with permission of the publisher. Copyright © 2016, John …

Quality of life in overweight and obese children and adolescents: a literature review

M Buttitta, C Iliescu, A Rousseau, A Guerrien - Quality of life research, 2014 - Springer
Purpose The purpose of the study is to present a literature review on quality-of-life (QOL)
assessment in overweight or obese children and adolescents in order to identify the most …

Immune checkpoint inhibitor myocarditis: pathophysiological characteristics, diagnosis, and treatment

…, J Lopez‐Mattei, JB Durand, C Iliescu… - Journal of the …, 2020 - Am Heart Assoc
Traditional cytotoxic chemotherapy and novel cancer therapies have various cardiotoxicities,
ranging from heart failure to arrhythmias. One of the most exciting developments in cancer …

Cardiotoxicity of the cancer therapeutic agent imatinib mesylate

…, L Grazette, R Yacobi, C Iliescu, R Patten, C Beahm… - Nature medicine, 2006 - nature.com
… toxic or that one of the targets of imatinib (c-Abl, Abl-related gene (Arg; also known as Abl-2),
platelet-derived growth factor (PDGF) receptor or c-Kit (the receptor for stem cell factor, SCF)…

A practical guide for the fabrication of microfluidic devices using glass and silicon

C Iliescu, H Taylor, M Avram, J Miao, S Franssila - Biomicrofluidics, 2012 - pubs.aip.org
This paper describes the main protocols that are used for fabricating microfluidic devices
from glass and silicon. Methods for micropatterning glass and silicon are surveyed, and their …

SCAI expert consensus statement: evaluation, management, and special considerations of cardio‐oncology patients in the cardiac catheterization laboratory …

CA Iliescu, CL Grines, J Herrmann… - Catheterization and …, 2016 - Wiley Online Library
In the United States alone, there are currently approximately 14.5 million cancer survivors,
and this number is expected to increase to 20 million by 2020. Cancer therapies can cause …

Harmonization process and reliability assessment of anthropometric measurements in a multicenter study in adolescents

…, Y Manios, L Beghin, C Iliescu… - International journal of …, 2008 - nature.com
Objective: To describe the standardization process and reliability of anthropometric and
bioelectrical impedance analysis (BIA) measurements. We examined both intra-and …

Cardiovascular health of patients with cancer and cancer survivors: a roadmap to the next level

…, MH Chen, AM Freeman, J Herrmann, C Iliescu… - Journal of the American …, 2015 - jacc.org
C. Iliescu, personal communication, December 2014). Since that time, this group has grown
into a comprehensive CV service, including interventional, electrophysiology, and advanced …

[PDF][PDF] De novo loss-of-function mutations in CHD2 cause a fever-sensitive myoclonic epileptic encephalopathy sharing features with Dravet syndrome

…, G Kluger, CM Iliescu, T Talvik, I Talvik, C Meral… - The American Journal of …, 2013 - cell.com
Dravet syndrome is a severe epilepsy syndrome characterized by infantile onset of therapy-resistant,
fever-sensitive seizures followed by cognitive decline. Mutations in SCN1A explain …

Characterization of masking layers for deep wet etching of glass in an improved HF/HCl solution

C Iliescu, J Jing, FEH Tay, J Miao, T Sun - Surface and Coatings …, 2005 - Elsevier
The paper presents a solution for improving the quality of the surface generated during deep
wet etching of glass using an HF (49%)/HCl (37%) solution in a volumetric ratio 10:1. Pyrex …